| 摘要 |
Compounds of formula I wherein I, R1-5 represents from one to five substituents independently selected from hydrogen, nitro, cyano, C1-C3-alkyl, halogen, carboxy, amino, trifluoromethyl, hydroxy, C1-C3-alkoxy groups, X is hydrogen, halo, N3, SH,═O,═CH2, an aromatic, preferably phenyl, ring optionally substituted by R1-5 groups as defined above, amino, mono- or disubstituted amino groups wherein the substituents are selected from C1-C4 alkyl, phenyl or benzyl groups optionally substituted by R1-5 groups as defined above Y is hydrogen, alkyl C1-C4, amino, or a group of formula—(CH2)0-1A wherein A is an aromatic, preferably phenyl, ring optionally substituted by R1-5 groups as defined above with the proviso that when X and Y are hydrogen, R1-5 cannot represent a 4-hydroxy or 4-alkoxy groups, are useful for the treatment of Tumor Necrosis Factor mediated immunopathological conditions as well as of diseases which may be treated or alleviated by inhibition of Interleukin-10 (IL-10). |
